GoodRx Holdings Inc
For the period ended Dec 31, 2023. Filed Feb 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 29, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| GOODRX HOLDINGS, INC. | ||
| Date: February 29, 2024 | By: | /s/ Karsten Voermann |
|---|---|---|
| Karsten Voermann | ||
| Chief Financial Officer | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant in the capacities and on the dates indicated.
| Name | Title | Date |
|---|---|---|
| /s/ Scott Wagner | Interim Chief Executive Officer | February 29, 2024 |
| Scott Wagner | (Principal Executive Officer) | |
| /s/ Karsten Voermann | Chief Financial Officer | February 29, 2024 |
| Karsten Voermann | (Principal Financial Officer) | |
| /s/ Romin Nabiey | Chief Accounting Officer | February 29, 2024 |
| Romin Nabiey | (Principal Accounting Officer) | |
| /s/ Christopher Adams | Director | February 29, 2024 |
| Christopher Adams | ||
| /s/ Trevor Bezdek | Chairman & Director | February 29, 2024 |
| Trevor Bezdek | ||
| /s/ Julie Bradley | Director | February 29, 2024 |
| Julie Bradley | ||
| /s/ Dipanjan Deb | Director | February 29, 2024 |
| Dipanjan Deb | ||
| /s/ Douglas Hirsch | Chief Mission Officer & Director | February 29, 2024 |
| Douglas Hirsch | ||
| /s/ Adam Karol | Director | February 29, 2024 |
| Adam Karol | ||
| /s/ Kelly J. Kennedy | Director | February 29, 2024 |
| Kelly J. Kennedy | ||
| /s/ Stephen LeSieur | Director | February 29, 2024 |
| Stephen LeSieur | ||
| /s/ Gregory Mondre | Director | February 29, 2024 |
| Gregory Mondre | ||
| /s/ Agnes Rey-Giraud | Director | February 29, 2024 |
| Agnes Rey-Giraud | ||
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
| Page | |
| Report of Independent Registered Public Accounting Firm (PCAOB ID 238) | F-1 |
|---|---|
| Consolidated Balance Sheets | F-3 |
| Consolidated Statements of Operations | F-4 |
| Consolidated Statements of Stockholders’ Equity | F-5 |
| Consolidated Statements of Cash Flows | F-6 |
| Notes to Consolidated Financial Statements | F-7 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.